Coverage
-
October 03, 2011
A New Jersey federal judge on Thursday dismissed a derivative shareholder suit against health giant Johnson & Johnson, ruling the complaint lacked facts to show that J&J executives ignored warning signs about drug recalls, kickback schemes and other damaging incidents.
1 other articles on this case.
View all »